Gerardo is a C-Level executive, serial entrepreneur, inventor, and scholar in the medical device industry. Gerardo founded five medical device companies and is a consultant to over 50 medical device companies in the Silicon Valley area. Gerardo is an advisory board member of the Santa Clara University (SCU) BioE, the…
Dr. Enrique Saldívar received his medical training at Universidad La Salle, received his MD from Universidad Autonoma de Mexico (UNAM), his Masters in Biomedical Engineering from Universidad Autonoma Metropolitana, and his Ph.D. in Bioengineering from the University of California, San Diego. Throughout his career, he has been appointed faculty at…
Hailing from a family of tech industrialists and medical thought leaders, Bjorn possesses a native drive and understanding for applying technologies to solve challenges in healthcare. Bjorn earned his M.Sc. in Accounting and Finance from the London School of Economics and B.Sc. from European Business School in Oestrich-Winkel, where he…
James Sapirstein has served over thirty-five years in the pharmaceutical industry. He is currently the President and CEO of AzurRx BioPharma (AZRX: NASDAQ). He has been part of almost two dozen drug product launches and specifically either led or has been a key member of several HIV product launches into…
Oscar Segurado is an executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development, and medical affairs. Oscar is Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics, and CellMax Life, Vice President for Becton Dickinson, and Global Medical Head for…
Jeff Galvin is the CEO and Founder of American Gene Technologies™ (AGT). He earned his BA degree in Economics from Harvard in 1981 and has more than 30 years of business and entrepreneurial experience including founder or executive positions at a variety of Silicon Valley startups. Several of his companies…
Latin America is undergoing dramatic demographic and epidemiological changes. Its population is rapidly aging, and there is a worrisome increase in the prevalence of chronic diseases. Despite this, innovative medical technologies sometimes take years to reach these patients. US and European Medical technology ("Medtech") companies struggle to find a cost-effective…
Zach Selch, the Global Sales Mentor, interviews Julio G. Martinez-Clark about his work with bioaccess™ helping foreign life science companies succeed in Latin America.
Dr. John B. Simpson (Founder & CEO, Avinger, Inc.) traveled to Cali, Colombia to run a clinical trial and talks about his experience. "I can only say good things about my experience here," he said.
bioaccess™ is a US-based contract research organization (CRO), regulatory, and market access consulting company that delivers a full spectrum of offerings from bench to commercialization so that foreign medical device companies can have long-term success in Colombia and the rest of Latin America. Our promise is for foreign medical device…
